Concentrix (NASDAQ:CNXC) Shares Down 5.4% Following Weak Earnings

Concentrix Corporation (NASDAQ:CNXC) was down 5.4% during trading on Wednesday following a weaker than expected earnings announcement. The stock traded as low as $25.44 and last traded at $25.0570. Approximately 1,952,025 shares were traded during mid-day trading, an increase of 33% from the average daily volume of 1,467,669 shares. The stock had previously closed at $26.48.

The company reported $2.61 earnings per share for the quarter, missing the consensus estimate of $2.65 by ($0.04). The business had revenue of $2.50 billion during the quarter, compared to the consensus estimate of $2.49 billion. Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.The firm’s revenue was up 5.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.79 earnings per share.

Concentrix Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, May 5th. Investors of record on Friday, April 24th will be issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 5.8%. The ex-dividend date of this dividend is Friday, April 24th. Concentrix’s dividend payout ratio (DPR) is currently -6.91%.

Trending Headlines about Concentrix

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Board declared a quarterly dividend of $0.36/share (≈5.3% yield) payable May 5; signals shareholder returns even amid earnings pressure.
• Positive Sentiment: Revenue and guidance: Q1 revenue rose to $2.50B (+5.4% YoY) and management maintained full‑year revenue and non‑GAAP EPS guidance; company highlighted AI/iX Suite enterprise momentum. Concentrix Reports First Quarter 2026 Results
• Positive Sentiment: Share repurchases: repurchased ≈1M shares in Q1 at ~$40/share with ~$396.6M remaining authorization — supports per‑share value over time.
• Neutral Sentiment: Liquidity/finance action: amended accounts receivable securitization facility — improves working‑capital flexibility but not a direct earnings driver. Concentrix Expands and Extends Accounts Receivable Securitization Facility
• Neutral Sentiment: Company held its Q1 earnings call and published the transcript/slide deck for investors to review — useful for color on margin drivers and AI wins. Earnings Call Transcript
• Neutral Sentiment: Short‑interest data in feeds appears inconsistent (reported as 0 shares) and should be treated with caution — no reliable signal from those entries.
• Negative Sentiment: Q1 earnings and cash flow weakness: reported EPS $2.61 vs. consensus ~$2.65; GAAP net income plunged ~69% YoY, diluted EPS down 68%, operating and adjusted EBITDA margins compressed, and operating cash flow/adjusted free cash flow were negative — profit and cash‑flow deterioration raises near‑term risk. Q1 Press Release / Financials
• Negative Sentiment: Analyst price‑target cuts: Barrington lowered target $62→$38, Canaccord cut $80→$55, Baird trimmed $52→$40 (ratings remain buy/outperform) — large downward PT revisions can pressure the stock and prompt re‑rating. Analyst Price Target Changes (Benzinga)
• Negative Sentiment: Investor skepticism: recent commentary (e.g., Seeking Alpha) argues valuation/margin risks mean the stock isn’t an attractive buy even after the big multiple compression. Why I’m Not Buying Concentrix

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on CNXC shares. Robert W. Baird decreased their price objective on Concentrix from $52.00 to $40.00 and set an “outperform” rating on the stock in a research note on Wednesday. Barrington Research cut their price objective on Concentrix from $62.00 to $38.00 and set an “outperform” rating for the company in a research note on Wednesday. Weiss Ratings lowered shares of Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a report on Thursday, January 29th. Canaccord Genuity Group decreased their target price on shares of Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a research note on Wednesday. Finally, Wall Street Zen upgraded shares of Concentrix from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $48.50.

Insider Activity at Concentrix

In other Concentrix news, CEO Christopher A. Caldwell bought 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 29th. The shares were bought at an average price of $37.07 per share, with a total value of $37,070.00. Following the purchase, the chief executive officer owned 362,075 shares of the company’s stock, valued at $13,422,120.25. This trade represents a 0.28% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.90% of the stock is owned by insiders.

Institutional Investors Weigh In On Concentrix

Institutional investors have recently added to or reduced their stakes in the stock. Huntington National Bank lifted its holdings in shares of Concentrix by 6,011.1% in the third quarter. Huntington National Bank now owns 550 shares of the company’s stock worth $25,000 after buying an additional 541 shares in the last quarter. Quent Capital LLC purchased a new position in Concentrix during the third quarter valued at $29,000. Larson Financial Group LLC grew its stake in Concentrix by 224.9% during the third quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock valued at $32,000 after acquiring an additional 479 shares in the last quarter. Geneos Wealth Management Inc. increased its holdings in Concentrix by 532.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after acquiring an additional 522 shares during the last quarter. Finally, Rothschild Investment LLC lifted its stake in Concentrix by 14,980.0% in the 3rd quarter. Rothschild Investment LLC now owns 754 shares of the company’s stock worth $35,000 after purchasing an additional 749 shares in the last quarter. 90.34% of the stock is owned by hedge funds and other institutional investors.

Concentrix Stock Performance

The firm’s 50 day simple moving average is $35.34 and its 200 day simple moving average is $40.33. The firm has a market cap of $1.54 billion, a PE ratio of -1.20, a PEG ratio of 0.35 and a beta of 0.50. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.67.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.